Planned phase I trial investigating TKM ALDH2 in healthy volunteers

Trial Profile

Planned phase I trial investigating TKM ALDH2 in healthy volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 16 Oct 2013

At a glance

  • Drugs TKM ALDH2 (Primary)
  • Indications Alcoholism
  • Focus Adverse reactions
  • Sponsors Arbutus Biopharma
  • Most Recent Events

    • 16 Oct 2013 New trial record
    • 08 Oct 2013 An IND for TKM ALDH2 is expected to be filed in the second half of 2014, with phase I data available in 2015, according to a Tekmira Pharmaceuticals Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top